Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, vol.15, pp.11-20, 2018. ,
United Kingdom, and United States for the period 2016-2030, J Hepatol, 2018. ,
MicroRNAs in metabolism and metabolic disorders, Nat Rev Mol Cell Biol, vol.13, pp.239-50, 2012. ,
miR-122-a key factor and therapeutic target in liver disease, J Hepatol, vol.62, pp.448-57, 2015. ,
Treatment of HCV infection by targeting microRNA, N Engl J Med, vol.368, pp.1685-94, 2013. ,
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial, Lancet, vol.389, pp.709-726, 2017. ,
Silencing of microRNAs in vivo with 'antagomirs', Nature, vol.438, pp.685-694, 2005. ,
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, Cell Metab, vol.3, pp.87-98, 2006. ,
LNA-mediated microRNA silencing in non-human primates, Nature, vol.452, pp.896-905, 2008. ,
Essential metabolic, antiinflammatory, and anti-tumorigenic functions of miR-122 in liver, J Clin Invest, vol.122, pp.2871-83, 2012. ,
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, J Clin Invest, vol.122, pp.2884-97, 2012. ,
Loss of miR122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties, Oncogene, vol.28, pp.3526-3562, 2009. ,
Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease, Gastroenterology, vol.122, pp.238-52, 2018. ,
Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues, Gastroenterology, vol.153, pp.1404-1419, 2017. ,
Dynamics of plasma lipoproteins and lipids during double filtration plasmapheresis (DEP), Jpn J Med, vol.26, pp.176-185, 1987. ,
Horizontal transfer of microRNAs: molecular mechanisms and clinical applications, Protein Cell, vol.3, pp.28-37, 2012. ,
Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice, Endocrinology, vol.153, pp.631-677, 2012. ,
Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARgamma, Proc Natl Acad Sci U S A, vol.110, pp.18656-61, 2013. ,
RORalpha controls hepatic lipid homeostasis via negative regulation of PPARgamma transcriptional network, Nat Commun, vol.8, p.162, 2017. ,
Liver-enriched transcription ,